In new independent research reports released early this morning,
Market Source Research released its latest key findings for all
current investors, traders, and shareholders of FireEye, Inc.
(NASDAQ:FEYE), CSRA Inc. (NYSE:CSRA), Concho Resources Inc.
(NYSE:CXO), Trevena, Inc. (NASDAQ:TRVN), Five Prime Therapeutics,
Inc. (NASDAQ:FPRX), and Endocyte, Inc. (NASDAQ:ECYT), including
updated fundamental summaries, consolidated fiscal reporting, and
fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
FEYE DOWNLOAD:
http://MarketSourceResearch.com/register/?so=FEYE
CSRA DOWNLOAD:
http://MarketSourceResearch.com/register/?so=CSRA
CXO DOWNLOAD:
http://MarketSourceResearch.com/register/?so=CXO
TRVN DOWNLOAD:
http://MarketSourceResearch.com/register/?so=TRVN
FPRX DOWNLOAD:
http://MarketSourceResearch.com/register/?so=FPRX
ECYT DOWNLOAD:
http://MarketSourceResearch.com/register/?so=ECYT
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Market Source
Research, available for free download at the links above, examine
FireEye, Inc. (NASDAQ:FEYE), CSRA Inc. (NYSE:CSRA), Concho
Resources Inc. (NYSE:CXO), Trevena, Inc. (NASDAQ:TRVN), Five Prime
Therapeutics, Inc. (NASDAQ:FPRX), and Endocyte, Inc. (NASDAQ:ECYT)
on a fundamental level and outlines the overall demand for their
products and services in addition to an in-depth review of the
business strategy, management discussion, and overall direction
going forward. Several excerpts from the recently released reports
are available to today's readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All information in
this release was accessed November 28th, 2017. Percentage
calculations are performed after rounding. All amounts in millions
(MM), except per share amounts.
-----------------------------------------
FIREEYE, INC. (FEYE) REPORT OVERVIEW
FireEye's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, FireEye reported revenue of $189.60MM vs
$186.41MM (up 1.71%) and basic earnings per share -$0.41 vs -$0.75.
For the twelve months ended December 31st, 2016 vs December 31st,
2015, FireEye reported revenue of $714.11MM vs $622.97MM (up
14.63%) and basic earnings per share -$2.94 vs -$3.50. FireEye is
expected to report earnings on February 1st, 2018. The report will
be for the fiscal period ending December 31st, 2017. The reported
EPS for the same quarter last year was -$0.22. The estimated EPS
forecast for the next fiscal year is -$0.86 and is expected to
report on February 1st, 2018.
To read the full FireEye, Inc. (FEYE) report, download it here:
http://MarketSourceResearch.com/register/?so=FEYE
-----------------------------------------
CSRA INC. (CSRA) REPORT OVERVIEW
CSRA's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, CSRA reported revenue of $1,272.00MM vs
$1,263.00MM (up 0.71%) and basic earnings per share $0.46 vs $0.46
(unchanged). For the twelve months ended March 31st, 2017 vs March
31st, 2016, CSRA reported revenue of $4,993.00MM vs $4,250.00MM (up
17.48%) and basic earnings per share $1.86 vs $0.54 (up 244.44%).
CSRA is expected to report earnings on February 6th, 2018. The
report will be for the fiscal period ending December 31st, 2017.
The reported EPS for the same quarter last year was $0.48. The
estimated EPS forecast for the next fiscal year is $2.08 and is
expected to report on May 23rd, 2018.
To read the full CSRA Inc. (CSRA) report, download it here:
http://MarketSourceResearch.com/register/?so=CSRA
-----------------------------------------
CONCHO RESOURCES INC. (CXO) REPORT
OVERVIEW
Concho Resources' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Concho Resources reported revenue of
$627.00MM vs $430.00MM (up 45.81%) and basic earnings per share
-$0.77 vs -$0.38. For the twelve months ended December 31st, 2016
vs December 31st, 2015, Concho Resources reported revenue of
$1,634.99MM vs $1,803.57MM (down 9.35%) and basic earnings per
share -$10.85 vs $0.54. Concho Resources is expected to report
earnings on February 20th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was $0.20. The estimated EPS forecast for the
next fiscal year is $2.31 and is expected to report on February
20th, 2018.
To read the full Concho Resources Inc. (CXO) report, download it
here:
http://MarketSourceResearch.com/register/?so=CXO
-----------------------------------------
TREVENA, INC. (TRVN) REPORT OVERVIEW
Trevena's Recent Financial Performance
For the twelve months ended December 31st, 2016
vs December 31st, 2015, Trevena reported revenue of $3.75MM vs
$6.25MM (down 40.00%) and basic earnings per share -$1.97 vs
-$1.15. Trevena is expected to report earnings on March 14th, 2018.
The report will be for the fiscal period ending December 31st,
2017. The reported EPS for the same quarter last year was -$0.67.
The estimated EPS forecast for the next fiscal year is -$0.95 and
is expected to report on March 14th, 2018.
To read the full Trevena, Inc. (TRVN) report, download it here:
http://MarketSourceResearch.com/register/?so=TRVN
-----------------------------------------
FIVE PRIME THERAPEUTICS, INC. (FPRX) REPORT
OVERVIEW
Five Prime Therapeutics' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Five Prime Therapeutics reported revenue
of $8.33MM vs $6.68MM (up 24.75%) and basic earnings per share
-$1.54 vs -$0.72. For the twelve months ended December 31st, 2016
vs December 31st, 2015, Five Prime Therapeutics reported revenue of
$30.69MM vs $379.80MM (down 91.92%) and basic earnings per share
-$2.44 vs $9.73. Five Prime Therapeutics is expected to report
earnings on February 22nd, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was -$0.73. The estimated EPS forecast for the
next fiscal year is -$5.00 and is expected to report on February
22nd, 2018.
To read the full Five Prime Therapeutics, Inc. (FPRX) report,
download it here:
http://MarketSourceResearch.com/register/?so=FPRX
-----------------------------------------
ENDOCYTE, INC. (ECYT) REPORT OVERVIEW
Endocyte's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Endocyte reported revenue of $0.03MM vs
$0.03MM (unchanged) and basic earnings per share -$0.55 vs -$0.21.
For the twelve months ended December 31st, 2016 vs December 31st,
2015, Endocyte reported revenue of $0.07MM vs $0.07MM (unchanged)
and basic earnings per share -$1.04 vs -$0.98. Endocyte is expected
to report earnings on March 9th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was -$0.26. The estimated EPS forecast for
the next fiscal year is -$0.91 and is expected to report on March
9th, 2018.
To read the full Endocyte, Inc. (ECYT) report, download it here:
http://MarketSourceResearch.com/register/?so=ECYT
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research
reports that help serious investors, registered brokers,
professional traders, and personal investment advisers find
reliable information in today's markets. Market Source Research's
team is comprised of financial professionals, many of which hold
Chartered Financial Analyst® (CFA®) designations and FINRA®
BrokerCheck® certifications. Whether identifying emerging trends,
or discovering new opportunity, the team at Market Source Research
is dedicated to providing accurate, informative, and objective
content that's ahead of the curve. With insights on individual
companies as well as sectors, readers get the industry's best
available combination of big-picture perspective as well as
granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit
staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Market Source Research's roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Market Source
Research have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Market Source Research's
Compliance department by Phone, at +1 (704) 343-6361, or by E-mail
at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Market Source
Research, Market Source Research members, and/or Market Source
Research affiliates are not responsible for any gains or losses
that result from the opinions expressed. Market Source Research
makes no representations as to the completeness, accuracy, or
timeliness of the material provided and all materials are subject
to change without notice. Market Source Research has not been
compensated for the publication of this press release by any of the
above mentioned companies. Market Source Research is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Hugo Moreau, Media Department
Office: +1 (704) 343-6361 E-mail:
media@MarketSourceResearch.com
© 2017 Market Source Research. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
FireEye (NASDAQ:FEYE)
Historical Stock Chart
From Mar 2024 to Apr 2024
FireEye (NASDAQ:FEYE)
Historical Stock Chart
From Apr 2023 to Apr 2024